Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-037519
Filing Date
2022-06-16
Accepted
2022-06-16 17:11:08
Documents
1
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4176
  Complete submission text file 0001209191-22-037519.txt   5594
Mailing Address C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Patterson Matthew R (Reporting) CIK: 0001401018 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39979 | Film No.: 221021437

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)